Validation of a spectrophotometric analytical method for quantifying stable metabolites of nitric oxide in biological fluids;Validación de un método analítico espectrofotométrico para la cuantificación de metabolitos estables de óxido nítrico en fluidos biológicos

Revista Mexicana de Ciencias Farmaceuticas

Volumn 36, Issue 1, 2005, Pages 31-41

  Tenorio López, Fermín Alejandro ^a,b   Del Valle M, Leonardo ^a   Pastelín H, Gustavo ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b Departamento de Farmacología   (Mexico)

Author keywords

Nitric oxide; Spectrometry; UV Vis; Validation

Indexed keywords

NITRIC OXIDE;

ACCURACY; ANALYTIC METHOD; ARTICLE; BODY FLUID; CHEMICAL REACTION; METABOLITE; QUANTITATIVE ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 18344375290     PISSN: 10273956     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kelm M. 1999. Nitric oxide metabolism and breakdown. Biochimica et Biophysica Acta, 1411: 273-289.
2. Wadsworth T.L., Koop D.R. 2001. Effects of Ginkgo biloba extract (Egb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chemico-Biological Interactions, 137: 43-58.
3. Guevara I., Iwannejko J., Dembinska-Kieé A., Pankiewicz J., Wanat A., Anna P., Golabek I., Bartus S., Malczewska-Malek M., Szczudlik A. 1998. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clinica Chimica Acta, 274: 177-178.
4. Macherzynski M., Bilecki W., Gorecki J., Przewlocki R., Golas J. 2000. Electrochemical and UV-Vis spectroscopic measurements of nitric oxide in fibroblasts and astrocytes. Electroanalysis, 12(13): 1046-1050.
5. Pénzeli P., Dózsa L., Degn H. 1998.The copper catalysed reduction of nitric oxide by ammonia in aqueous solution studied by membrane inlet mass spectrometry. Journal of Molecular Catalysis A: Chemical, 136: 235-242.
6. Carini M., Aldini G., Orioli M., Piccoli A., Tocchetti P., Facino RM. 2004. Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 35(2): 277-287.
7. Kelm M., Freelisch M., Grube R., Motz W., Strauer B.E. Nitric Oxide. En: Moncada S., Marietta M.A., Hibbs J.B., Higgs E.A. (eds.), The biology of nitric oxide. 1 Physiological and clinical aspects. Portland Press, London, pp. 319-322.
8. Hosaka H., Uozumi M., Tuyuma I. 1989. The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor. Free Radical Biol Med, 7: 653-658.
9. - in aqueous and protein-containing samples. Nitric Oxide: Biology and Chemistry, 3(3): 225-224.
10. Moshage H., Kok B., Huizenga J.R., Jansen P.L.M. 1995. Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry, 41(6): 892-896.
11. Muñoz-Fuentes RM, Vargas F, Bobadilla NA. 2003. Assay validation for determining nitrites and nitrates in biological fluids. Revista de Investigación Clínica, 55(6): 670-676.
12. a ed. McGraw-Hill, New York, pp. 699-702.
13. Ewing J.F., Janero D.R. 1998. Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium (III) reduction and ozone-chemiluminiscent detection. Free Radical Biol Med, 25(4/5): 621-628.
14. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline: text on validation of analytical procedures. 1994.
15. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline: validation of analytical procedures methodology. 1996.
16. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM). Guidance for industry: bioanalytical method validation. 2001.
17. Butler A. 1990. Vanadium in biological systems, Kluwer Press, Dordecht, pp. 25-49.
18. Nechay B.R. 1984. Mechanisms of action of vanadium. Annual Reviews of Pharmacology and Toxicology, 24: 501-524.
19. Hudson T.O.F. 1964. Vanadium: toxicology and biological significance, Elsevier Publishing Co, Amsterdam, pp. 35-50.
20. Wei C.I., Al Bayati M.A., Culbertson M.R., Rosenblatt L.S., Hansen L.D. 1982. Acute toxicity of ammonium metavanadate in mice. Journal of Toxicology and Environmental Health, 10(4-5): 673-687.
21. Nielsen F.H., Uthus E.O. 1990. The essenciality of metabolism of vanadium. En: Chasteen D. (ed.), Vanadium in biological systems, Kluwer Academic Publishers, Boston, pp. 15-20.
22. Marzinzig M., Nussler A. K., Stadler J., Marzinzig E., Barthlen W., Nussler N.C., Beger H.G., Morris S.M., Brükner U.B. 1997. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate and S-nitrosothiols. Nitric Oxide: Biology and Chemistry, 1(2): 177-189.
23. Noda H., Minemoto M., Eto S., Noda A., Matsuyama K. 1984. Nitrite ion, its stability in an aqueous solution and disappearance from rabbit blood. Yakugaku Zasshi, 104: 409-412.
24. Green L.C., Luzuriaga K.R., Wagner D.A., Rand W., Istfan N., Young V.R., Tannebaum S.R. 1981. Nitrate biosynthesis in man. Proceedings of the National Academy of Sciences, 34: 7764-7768.
25. Ricart-Jane D., Llobera M., Lopez-Tejero MD. 2002. Anticoagulants and other preanalytical factors interfere in plasma nitrate/nitrite quantification by the Griess method. Nitric Oxide, 6(2): 178-185.